Guangxi Wuzhou Zhongheng Group announced that on November 27, 2024, the company disclosed a preliminary announcement regarding its intention to transfer 23.43% of its shares in Chongqing Lummy Pharmaceutical through public solicitation of transferees. On December 12, 2024, the company received a notification from its controlling shareholder, Guangxi Investment Group Co., Ltd., that the transfer plan has been approved by the State-owned Assets Supervision and Administration Commission of the Guangxi Zhuang Autonomous Region, in principle agreeing to the intention to solicit transferees for Guangxi Wuzhou Zhongheng Group's 247,426,064 A-share holdings in Chongqing Lummy Pharmaceutical.
中恒集团：拟以公开征集受让方方式转让莱美药业23.43%股份获广西国资委批复
Guangxi Wuzhou Zhongheng Group: intends to transfer 23.43% of its shares in Chongqing Lummy Pharmaceutical through public solicitation of transferees, approved by the Guangxi State-owned Assets Supervision and Administration Commission.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated